In vitro activity of josamycin against Streptococcus pyogenes isolated from patients with upper respiratory tract

M Auzou1, J Caillon2, C Poyart3

  • 1Service de microbiologie et CNR associé de la résistance aux antibiotiques, CHU de Caen, 14033 Caen, France.

Abstract

Insights

Josamycin demonstrates high activity against Streptococcus pyogenes, with over 95% susceptibility observed in isolates from upper respiratory tract infections. This macrolide antibiotic can serve as an alternative treatment for pharyngitis.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Streptococcus pyogenes is a common cause of upper respiratory tract infections.
  • Macrolide resistance in S. pyogenes is a growing concern.
  • Josamycin is a macrolide antibiotic with potential therapeutic applications.

Purpose of the Study:

  • To evaluate the in vitro activity of josamycin against clinical isolates of S. pyogenes.
  • To determine the prevalence of macrolide resistance mechanisms in these isolates.
  • To assess josamycin's potential as an alternative treatment for S. pyogenes infections.

Main Methods:

  • Broth microdilution method was used to determine Minimum Inhibitory Concentrations (MICs) for josamycin and other antibiotics.
  • Polymerase Chain Reaction (PCR) was employed to screen for key macrolide resistance genes (erm(B), erm(TR), mef(A)).
  • Susceptibility testing was performed on 193 S. pyogenes isolates from French patients.

Main Results:

  • Josamycin exhibited potent activity with MIC50 and MIC90 values of 0.12 and 0.25 mg/L, respectively.
  • The overall resistance rate to josamycin was low, estimated at 4.7%.
  • The erm(B) gene was identified as the primary mechanism of resistance in resistant isolates, while erm(TR) and mef(A) were associated with susceptibility.

Conclusions:

  • Josamycin demonstrated significant in vitro activity against the majority of S. pyogenes isolates.
  • The findings support the use of josamycin as a viable alternative therapeutic option for pharyngitis caused by S. pyogenes.
  • Understanding resistance mechanisms is crucial for guiding antibiotic selection.

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.0K
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
89
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
6.1K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
132
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
100
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
66